Pain Medicine Doctors in Fort Lauderdale, FL Accepting Medicare

3 Pain Medicine doctors found. Showing 1 - 3

Dr. Giuseppe Gabriele Paese, D.O. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 6000 N Federal Hwy, Fort Lauderdale, FL 33308 Phone: 954-771-2551    Fax: 954-492-5266

Dr. Marcos Szeinfeld, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1930 Ne 47th St, Fort Lauderdale, FL 33308 Phone: 954-493-5048    Fax: 954-493-6424

Dr. Sergio Lenchig, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1930 Ne 47th Street, Suite. 300, Fort Lauderdale, FL 33308 Phone: 954-493-5048    Fax: 954-493-6424

News Archive

Transfer learning technique achieves 99.24% success when detecting COVID-19 in chest x-rays

Results of this technique, known as transfer learning, achieved a 99.24 per cent success rate when detecting COVID-19 in chest x-rays.

Scientists develop highly efficient approach for cardiac imaging

Scientists of the Charité - Universitätsmedizin Berlin and the Max-Delbrück-Center for Molecular Medicine Berlin-Buch have developed a highly efficient approach for imaging the beating human heart.

Underwriters exercise over-allotment option in Uroplasty's common stock public offering

Uroplasty, Inc. announced today that the underwriters for the recently announced public offering of Uroplasty common stock have exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company's common stock. The 4,600,000 shares of Uroplasty common stock in the offering, including the 600,000 shares subject to the over-allotment option, are being sold at a price to the public of $3.50 per share.

Novel method can edit genes with substantially fewer errors

Gene therapy is an emerging strategy to treat diseases caused by genetic abnormalities. One form of gene therapy involves the direct repair of a defective gene, using genome-editing technology such as CRISPR-Cas9. Despite its therapeutic potential, genome editing can also introduce unwanted and potentially harmful genetic errors that limit its clinical feasibility.

Tool to predict potential ovarian failure after radiation

Doctors in the United Kingdom have created a table to predict when a woman who has undergone radiation therapy as a part of cancer treatment regimen in her abdominal or pelvic area may become sterile

Read more Medical News

› Verified 1 days ago